Brief: Acura Pharmaceuticals Inc says FDA has provided company with advice on development of its product candidate LTX-04

Acura Pharmaceuticals

14/12/2016 21:21

Dec 14 (Reuters) - Acura Pharmaceuticals Inc  ACUR.O : 
    * Acura Pharmaceuticals says FDA confirmed company's stated 
direction to reformulate ltx-04 to provide greater levels of 
drug in blood stream 
    * Acura Pharmaceuticals - in study ap-ltx-400, ltx-04 
tablets delivered about 50% of maximum drug concentration in 
blood stream 
    * Acura Pharmaceuticals Inc says U.S. FDA has provided 
company with advice on continued development of its product 
candidate ltx-04 
    * Says FDA's advice also identified longer term studies 
necessary for submitting a new drug application for ltx-04 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nMKWvhtVVa 
Further company coverage:  ACUR.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))